ADB-20226-11471
3 vaccinations
6 coded responses
7 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 554 / MN
- Registered
- 2021-11-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Moderna
-
2021-04-27
Dose 2 — Moderna
-
2021-11-15
Dose 3 — Moderna
-
2021-11-19
Registered in v-safe
-
2021-11-19
Survey response — days 1–6 daily, dose 3MedDRA: Heart rate increased, Hypertension — Feeling: Poor · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Rapid heartbeat and hypertensionMedDRA releases: 2024-11 · check-in free text available
- 2021-11-22
-
2021-12-14
Survey response — day 28, dose 3MedDRA: Abdominal distension, Arthralgia, Dizziness, Hypertension, Lymphadenopathy, Tachycardia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Hypertension, tachycardia, bloating, swollen nodes, joint pain, dizziness.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-20
Survey response — day 35, dose 3MedDRA: Arthralgia, Blood pressure increased, Fatigue, Heart rate increased, Lymphadenopathy, Muscular weakness, Paraesthesia, Skin infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Skin infections, swollen lymph nodes and fatigue. Rapid heartbeat. Spikes in blood pressure. Muscle weakness and tingling/painful joints and extremities.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-15
Survey response — 3 months, dose 3MedDRA: Amnesia, Fatigue, Visual impairment — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Severe fatigue, vision changes, memory loss.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Survey response — 6 months, dose 3MedDRA: Hepatic steatosis, Malabsorption, Tachycardia, Tremor, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Tachycardia, fatty liver, and malabsorption. Tremors, vision changes.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-05-17
-
2022-11-15
Survey response — 12 months, dose 3MedDRA: Bacterial vaginosis, Diarrhoea, Fatigue, Food intolerance, Fungal infection, Lymphadenopathy, Pyrexia, Skin infection, Tachycardia, Urticaria — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Fever, hives, tachycardia, diarrhea, non-stop skin infections on my face and in my ears and nose. Bacterial vaginosis. Yeast infection. Food sensitivity. Severe fatigue. Swollen lymph nodes.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-11-16
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Moderna | No |
| 2 | 2021-04-27 | Moderna | No |
| 3 | 2021-11-15 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Rapid heartbeat and hypertension
Release 10 — day 28, dose 3
Symptoms: Hypertension, tachycardia, bloating, swollen nodes, joint pain, dizziness.
Release 10 — day 35, dose 3
Symptoms: Skin infections, swollen lymph nodes and fatigue. Rapid heartbeat. Spikes in blood pressure. Muscle weakness and tingling/painful joints and extremities.
Release 11 — 3 months, dose 3
Symptoms: Severe fatigue, vision changes, memory loss.
Release 11 — 6 months, dose 3
Symptoms: Tachycardia, fatty liver, and malabsorption. Tremors, vision changes.
Release 12 — 12 months, dose 3
Symptoms: Fever, hives, tachycardia, diarrhea, non-stop skin infections on my face and in my ears and nose. Bacterial vaginosis. Yeast infection. Food sensitivity. Severe fatigue. Swollen lymph nodes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal distension | · | · | ✓ |
| SD | Amnesia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Bacterial vaginosis | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Food intolerance | · | · | ✓ |
| SD | Fungal infection | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hepatic steatosis | · | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Malabsorption | · | · | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Skin infection | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Tremor | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Hypertension | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release